Lung Cancer
📧 Sign up to get email alerts when something new happens for Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity [NA]
A completed clinical trial evaluating a patient-centered intervention to reduce financial toxicity in cancer patients, with results posted i…
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study [Phase 4]
Phase 4 clinical trial update on volatile anesthesia and perioperative outcomes in cancer patients; study completed.
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: PD1 and PARP for Maintenance Therapy in NSLLC [Phase 2]
A Phase 2 clinical trial update evaluating PD-1 and PARP inhibitors as maintenance therapy for lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating an immune checkpoint inhibitor combined with recombinant human endostatin for leptomeningeal metastasis fr…
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: VATS VS. Open Thoracic Surgery for Stage II - III Lung Cancer [Phase 3]
A Phase 3 clinical trial compares video-assisted thoracoscopic surgery (VATS) versus open thoracic surgery for stage II-III lung cancer; sta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.) [Phase 3]
A Phase 3 trial update for a respiratory rehabilitation software called Redpill Breath, evaluating its clinical effectiveness and safety in …
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Trial of Either Surgery or Stereotactic Radiotherapy for Early Stage (IA) Lung Cancer [Phase 3]
Phase 3 trial comparing surgery versus stereotactic radiotherapy for early-stage (IA) lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese [Phase 2]
An open-label multicenter Phase 2 study evaluating maintenance Durvalumab (MEDI4736) plus Olaparib in Chinese patients with lung cancer and …
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Prophylactic TCM for Mitigation of EGFR-TKI Related Dermatological Adverse Effect [Phase 3]
A Phase 3 clinical trial evaluating prophylactic traditional Chinese medicine (TCM) to mitigate dermatological adverse effects related to EG…
-
CLINICAL_TRIALS trial_result · 2022-01-21Clinical Trial Update: Hippocampus Avoidance PCI vs PCI [Phase 3]
Phase 3 clinical trial comparing hippocampus-avoidance prophylactic cranial irradiation (PCI) to standard PCI in small cell lung cancer and …
-
CLINICAL_TRIALS trial_result · 2022-01-21Clinical Trial Update: Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating durvalumab and tremelimumab in recurrent stage IV squamous cell lung carcinoma has completed with results …
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: Home Telemonitoring for Patients With Lung Cancer [NA]
Clinical trial update on home telemonitoring for patients with lung cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-30Clinical Trial Update: Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers [Phase 2, Phase 3]
Clinical trial update for Durvalumab as second-line therapy in recurrent stage IV squamous cell lung cancer without matching biomarkers; tri…
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: Auris Robotic Endoscopy System for Bronchoscopy [NA]
Clinical trial update for the Auris Robotic Endoscopy System in bronchoscopy has terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-20Clinical Trial Update: Goal Directed Therapy Versus Standard Care in Lung Resection Surgery (GDT-thorax Study). [NA]
Clinical trial comparing goal-directed therapy to standard fluid management during lung resection surgery has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Personal Resilience Empowerment Program Study [NA]
Clinical trial update for a study titled Personal Resilience Empowerment Program; status completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound [Phase 3]
Phase 3 trial investigating lidocaine administration during flexible bronchoscopy and endobronchial ultrasound; study terminated with result…
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II [NA]
Phase II clinical trial update evaluating palliative care interventions for outpatients recently diagnosed with lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: Evaluation of Computer-Aided Lung Nodule Detection Software in Thoracic CT for Riverain Technologies LLC [NA]
Clinical trial update on computer-aided lung nodule detection software evaluated in thoracic CT for Riverain Technologies; study completed w…
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 study results for INCB001158, an arginase inhibitor, as a single agent and in combination with immune checkpoint therapy, in patient…
-
CLINICAL_TRIALS trial_result · 2021-09-27Clinical Trial Update: ANET Electrosurgery Applicator Pilot Evaluation Study [NA]
A pilot evaluation study for an electrosurgery applicator related to lung cancer conditions has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Pain After Lung Cancer Surgery - Comparing Traditional Versus Prolonged Release Nerve Blockades [Phase 2]
Phase 2 trial evaluating traditional versus prolonged-release nerve blockades for postoperative pain after lung cancer surgery.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer [Phase 3]
Phase 3 trial evaluating megestrol for anorexia/cachexia in patients undergoing radiation therapy for lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating combination chemotherapy in extensive-stage small cell lung cancer has completed.